Key Insights

Highlights

Treatment Research

2 treatments under study, led by Laboratory Biomarker Analysis

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02336763Not ApplicableTerminated

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Showing all 1 trials

Research Network

Common Treatments

  • Laboratory Biomarker Analysis1
  • External Beam Radiation Therapy1

Active Sponsors

  • Jonsson Comprehensive Cancer Center1
  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Stage Iiib Uveal Melanoma1
  • Mediumlarge Size Posterior Uveal Melanoma1
  • Stage Iib Uveal Melanoma1
  • Stage Iiia Uveal Melanoma1
  • Iris Melanoma1

Activity Timeline